Longevity
  • News
  • Investment
  • Research
  • Lifestyle
  • Videos

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance
  • Team

Research

  • All reports
  • Upcoming reports
  • Biological age diagnostics
  • Longevity supplements
  • Aging in place
  • Senotherapeutics

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • About us
  • Contact
  • Features

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy
Posted on February 15, 2022May 13, 2022

“Rosetta Stone” of immune cell function revealed by CRISPR scientists

By adapting a variation of the CRISPR-Cas9 system, researchers are able to activate genes in human immune cells and study …

Continue reading ““Rosetta Stone” of immune cell function revealed by CRISPR scientists”

Posted on August 3, 2021May 12, 2022

Modified RNA CRISPR boosts gene knockdown in human cells

Modified RNA guides improve gene targeting for next-generation CRISPR tools and therapies. In the latest of ongoing efforts to expand …

Continue reading “Modified RNA CRISPR boosts gene knockdown in human cells”

Posted on May 3, 2021May 12, 2022

Can CRISPR be used to diagnose aging?

Irina Conboy talks CRISPR and how the gene-editing tech may have a significant role to play in diagnostics. In the …

Continue reading “Can CRISPR be used to diagnose aging?”

Posted on July 22, 2020May 11, 2022

New CRISPR-free gene-editing tool exploits bacterial warfare

New tool uses an interbacterial toxin to achieve precise mitochondrial gene editing without CRISPR side-effects. Mitochondria – often called the …

Continue reading “New CRISPR-free gene-editing tool exploits bacterial warfare”

Posted on May 7, 2020May 10, 2022

Wyss Institute and Cytosurge collaborate on CRISPR tech

The Wyss Institute at Harvard is joining forces with Swiss Biotech Cytosurge in a bid to improve CRISPR-based multiplexed gene …

Continue reading “Wyss Institute and Cytosurge collaborate on CRISPR tech”

Posted on March 12, 2020May 10, 2022

Better, faster, stronger CRISPR

Cytosurge claims to be able to make CRISPR “better and faster than anybody else on single cell level” – seeking investment to …

Continue reading “Better, faster, stronger CRISPR”

Posted on February 17, 2020May 10, 2022

Human CRISPR trial heralds Longevity success

Trial finds not only that gene-edited immune cells are safe, but that they survive and thrive after being placed into …

Continue reading “Human CRISPR trial heralds Longevity success”

Posted on January 15, 2020May 10, 2022

CRISPR in-body gene revolution gets underway

It has been an ethical minefield, but a scientific revolution. Could CRISPR in-body now be the next step in health …

Continue reading “CRISPR in-body gene revolution gets underway”

Posted on December 23, 2019May 10, 2022

Primetime for more powerful CRISPR tech

Researchers have developed a novel and more powerful form of CRISPR that offers the possibility to correct most disease-causing genetic …

Continue reading “Primetime for more powerful CRISPR tech”

Posts navigation

Page 1 Page 2 … Page 7 Next page

Find us here ...

Subscribe to our newsletter

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance
  • Team

Research

  • All reports
  • Upcoming reports
  • Biological age diagnostics
  • Longevity supplements
  • Aging in place
  • Senotherapeutics

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • About us
  • Contact
  • Features
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy
  • Conditions of Business
  • Terms and Conditions
  • Copyright Policy
© Copyright 2022 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.